Phase I Clinical Trials of Tezacitabine [(E)-2′-Deoxy-2′-(fluoromethylene)cytidine] in Patients with Refractory Solid Tumors von RODRIGUEZ, Gladys I, JONES, Richard E, ORENBERG, Elaine K, STOLTZ, Maxine L, BROOKS, Donald J

Volltext

Irinotecan (Iri) and buparlisib (B) in previously treated patients (pts) with metastatic colorectal cancer (mCRC) von Baranda, Joaquina Celebre, Reed, Greg, Williamson, Stephen K., Perez, Raymond P., Stoltz, Maxine L., Mackay, Chris, Madan, Rashna, Pessetto, Ziyan Y., Godwin, Andrew K.

Volltext

Development of an Oral Dosage Form of Azacitidine: Overcoming Challenges in Chemistry, Formulation, and Bioavailability von Stoltz, Maxine L., Etter, Jeffrey B., Obradovic, Tanja, Jia, Richard

Volltext

Phase II Study of the Cyclin-Dependent Kinase Inhibitor Flavopiridol Administered to Patients With Advanced Gastric Carcinoma von Schwartz, Gary K., Ilson, David, Saltz, Leonard, O’Reilly, Eileen, Tong, William, Maslak, Peter, Werner, Jeanine, Perkins, Pam, Stoltz, Maxine, Kelsen, David

Volltext

Phase I Study of the Cyclin-Dependent Kinase Inhibitor Flavopiridol in Combination With Paclitaxel in Patients With Advanced Solid Tumors von SCHWARTZ, Gary K, O'REILLY, Eileen, ENDRES, Sandra, BARAZZOUL, John, SPRIGGS, David, KELSEN, David, ILSON, David, SALTZ, Leonard, SHARMA, Sunil, TONG, William, MASLAK, Peter, STOLTZ, Maxine, EDEN, Larry, PERKINS, Pam

Volltext